Maria L. Ascierto, Ph.D. Saint John's Cancer Institute
Por um escritor misterioso
Descrição
Saint John's Cancer Institute's Director of Translational Immunology, Maria L. Ascierto, Ph.D. Contact Dr. Ascierto via email or phone number.
Resolving Cancer Heterogeneity: - PDF Free Download
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - Journal of Thoracic Oncology
Rosalie and Harold Rae Brown Cancer Immunotherapy Research Program
Santa Monica Melanoma Symposium - A CME Event - April 30th, 2022 - Saint John's Cancer Institute
Proceedings of a Workshop, The Drug Development Paradigm in Oncology: Proceedings of a Workshop
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy), Journal of Translational Medicine
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity
Pioneers in Immunotherapy - Saint John's Health Center Foundation
35th Anniversary Annual Meeting & Pre-Conference Programs Your guide to SITC 2020 by SITC Communications - Issuu
